Skip to main content
Log in

Kontinuierliche intrathekale Medikamentenapplikation

Anästhesiologische und intensivmedizinische Besonderheiten

Continuous intrathecal administration of medication

Special features in anaesthesiology and intensive care

  • Medizin aktuell
  • Published:
Der Anaesthesist Aims and scope Submit manuscript

Zusammenfassung

In der anästhesiologischen und intensivmedizinischen Praxis werden in zunehmendem Maß auch Patienten mit implantierten Medikamentenpumpen behandelt. Grundkenntnisse über die Besonderheiten dieser Therapiemethode sind deshalb wichtig. Im Rahmen der präanästhesiologischen Visite müssen Informationen über die Pumpe, den intrathekalen Katheter, Art und Dosierung der applizierten Medikamente sowie der nächste Befülltermin erfragt und dokumentiert werden. Punktionen im Bereich der Pumpe und des Katheterverlaufs müssen vermieden werden. Im Rahmen der intensivmedizinischen Betreuung müssen Wechselwirkungen sowie Über- oder Unterdosierungen der intrathekal verabreichten Medikamente bedacht werden. Die Kenntnis der Befülltermine und die rechtzeitige Organisation der Befüllung sind wesentlich, um Komplikationen zu vermeiden.

Abstract

In anaesthesiological and intensive care practice patients are inceasingly being treated with implanted medication pumps. Basic knowledge on the special aspects of this form of therapy is therefore important. During the preanasthesiology visit, information on the pump, the intrathecal catheter, type and dosage of the medication as well as the next scheduled refilling must be collected and documented. Needle punctures near the pump and the catheter must be avoided. During intensive care treatment any possible interaction and overdosing or underdosing of the intrathecally administered medication must be considered. Information on the schedule and punctual organisation of refilling are important to avoid complications.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2
Abb. 3
Abb. 4
Abb. 5

Literatur

  1. Anderson VC, Burchiel KJ (1999) A prospective study of long-term intrathecal morphine in the management of chronic nonmalignant pain. Neurosurgery 44: 289–300

    Article  PubMed  CAS  Google Scholar 

  2. Avellino AM, Loeser JD (2000) Intrathecal baclofen for the treatment of intractable spasticity of spine or brain etiology. Neuromodulation 3: 75–81

    Article  Google Scholar 

  3. Coffey RJ, Edgar TS, Francisco GE et al. (2002) Abrupt withdrawal from intrathecal baclofen: recognition and management of a potentially life-threatening syndrome. Arch Phys Med Rehabil 83: 735–741

    Article  PubMed  Google Scholar 

  4. Creedon SD, Dijkers MPJM, Hinderer SR (1997) Intrathecal baclofen for severe spasticity: a meta-analysis. Int J Rehab Health 3: 171–185

    Google Scholar 

  5. Darouiche RO (2004) Treatment of infections associated with surgical implants. N Engl J Med 350: 1422–1429

    Article  PubMed  CAS  Google Scholar 

  6. Hassenbusch SJ, Pillay PK, Magdinec M et al. (1990) Constant infusion of morphine for intractable cancer pain using an implanted pump. J Neurosurg 73: 405–409

    Article  PubMed  CAS  Google Scholar 

  7. Kumar K, Hunter G, Demeria DD (2002) Treatment of chronic pain by using intrathecal drug therapy compared with conventional pain therapies: a cost-effectiveness analysis. J Neurosurg 97: 803–810

    PubMed  Google Scholar 

  8. Lierz P, Tüchy G, Felleiter P (1999) Rückenmarknahe Schmerztherapie. Eine Statuserhebung in Deutschland und Österreich. Schmerz 13: 127–132

    Article  PubMed  CAS  Google Scholar 

  9. Onofrio BM, Yaksh TL (1990) Long-term pain relief produced by intrathecal morphine infusion in 53 patients. J Neurosurg 72: 200–209

    PubMed  CAS  Google Scholar 

  10. Penn RD (1992) Intrathecal baclofen for spasticity of spinal origin: seven years of experience. J Neurosurg 77: 236–240

    PubMed  CAS  Google Scholar 

  11. Plassat R, Verbe BP, Menei P et al. (2004) Treatment of spasticity with intrathecal baclofen administration: long-term follow-up, review of 40 patients. Spinal Cord 42: 686–693

    Article  PubMed  CAS  Google Scholar 

  12. Roberts LJ, Finch PM, Goucke CR, Price LM (2001) Outcome of intrathecal opioids in chronic non-cancer pain. Eur J Pain 5: 353–361

    Article  PubMed  CAS  Google Scholar 

  13. Sampson FC, Hayward A, Evans G et al. (2002) Functional benefits and cost/benefit analysis of continuous intrathecal baclofen infusion for the management of severe spasticity. J Neurosurg 96: 1052–1057

    PubMed  Google Scholar 

  14. Thompson JC, Dunbar E, Laye RR (2006) Treatment challenges and complications with ziconotide monotherapy in established pump patients. Pain Physician 9: 147–152

    PubMed  Google Scholar 

  15. Tsuji C, Saito H, Hatano K (1997) Leg pain under spinal anesthesia in leprosy patients. Masui 46: 704–707

    PubMed  CAS  Google Scholar 

  16. Wang JK, Nauss LA, Thomas JE (1979) Pain relief by intrathecally applied morphine in man. Anesthesiology 50: 149–151

    Article  PubMed  CAS  Google Scholar 

  17. Winkelmüller M, Winkelmüller W (1991) Intrathekale Opiattherapie bei chronischen Schmerzsyndromen benigner Ätiologie über implantierbare Medikamentenpumpen. Schmerz 5: 28–36

    Article  PubMed  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to P. Felleiter.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Felleiter, P., Lierz, P. Kontinuierliche intrathekale Medikamentenapplikation. Anaesthesist 56, 822–827 (2007). https://doi.org/10.1007/s00101-007-1204-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00101-007-1204-y

Schlüsselwörter

Keywords

Navigation